3Bou G,Oliber A,Martinez-Behran J.OXA-24,a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannil clinical strain[J].Antimicrob Agents Chemother,2000,44(6):1556. 被引量：1
4MANIKAL V M,LANDMAN D,SAURINA G,et al.Endemic carbapen Emresistant Acinetobacter species in Brooklyn,New York:citywide prevalence,imerinstitutional spread,and relation to antibiotic usage[J].Clin Infect Dis,2000,31:101-106. 被引量：1
6Von Graevenitz A.Acinetobacter,alcaligenes,moraxella,and other nonfermentative gram negative bacteria[A].Murray PR Manual Society for Microbiology,1995:520. 被引量：1
7Towner KJ.Clinical impotance and antibiotic resistance of Acinetobacter spp[J].J Med Microbiol,1997,46:721-746. 被引量：1
8Coelho JM,Turton JF,Kaufmann ME,et al.Occurrence of carbapenem-resistant acinetobacter baumannii clones at multiple hospitals in London and Southeast England[J].Journal of Clinical Microbiology,2006,10(4):3623-3627. 被引量：1
9National Committee for Clinical Labortory Standards for antimicrobial susceptibility testing[M].Ninth informational standards.Performance Standards M100-S9.Pennsylvania: NCCLS, 1999.1-103. 被引量：1
